Aptargroup (ATR) Cash from Financing Activities (2009 - 2026)
Aptargroup's (ATR) quarterly Cash from Financing Activities came in at -$230.3 million in Q1 2026, down 70.9% year-on-year from -$791.7 million in Q1 2025, and down 400.09% on a QoQ basis from $76.8 million in Q4 2025.
Aptargroup (ATR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Cash from Financing Activities data on file, last reported at -$230.3 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 70.9% year-over-year to -$230.3 million in Q1 2026; TTM through Mar 2026 was -$173.0 million, a 46.66% increase from a year earlier, with the FY2025 full-year figure at -$77.5 million, up 65.62% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$230.3 million, down from $76.8 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for ATR reached as high as $211.9 million in Q1 2022 and fell as low as -$230.3 million in Q1 2026.
- Historically, Cash from Financing Activities has averaged -$51.0 million across 5 years, with a median of -$53.3 million in 2024.
- On a YoY basis, Cash from Financing Activities climbed as much as 570.77% in 2022 and fell as far as 32697.49% in 2022.
- Year by year, Cash from Financing Activities stood at -$82.0 million in 2022, then grew by 5.42% to -$77.5 million in 2023, then slipped by 13.09% to -$87.7 million in 2024, then surged by 187.53% to $76.8 million in 2025, then plunged by 400.09% to -$230.3 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$230.3 million in Q1 2026, $76.8 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Aptargroup | 9.43 Bn | 9.23 Bn | 351.91 Mn | -230.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -230.34 Mn |
| Mar 31, 2026 | -230.34 Mn |
| Dec 31, 2025 | 76.76 Mn |
| Dec 31, 2025 | 76.76 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | -27.27 Mn |
| Jun 30, 2025 | -27.27 Mn |
| Mar 31, 2025 | -134.78 Mn |
| Mar 31, 2025 | -134.78 Mn |
| Dec 31, 2024 | -87.69 Mn |
| Dec 31, 2024 | -87.69 Mn |
| Sep 30, 2024 | -48.64 Mn |
| Sep 30, 2024 | -48.64 Mn |
| Jun 30, 2024 | -53.26 Mn |
| Jun 30, 2024 | -53.26 Mn |
| Mar 31, 2024 | -35.75 Mn |
| Mar 31, 2024 | -35.75 Mn |
| Dec 31, 2023 | -77.54 Mn |
| Dec 31, 2023 | -77.54 Mn |